hepatitis Apr 14, 2021 GlycoPath to Develop MALDI Mass Spec Test for Liver Fibrosis Premium Apr 2, 2021 Abbott Focuses on Future Pandemic Preparedness With New Global Diagnostics Coalition Premium Mar 16, 2021 Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing Premium Mar 11, 2021 Roche Cobas HIV, Hepatitis C Tests Nab WHO Prequalification Mar 9, 2021 DiaSorin, Roche, Inova Diagnostics Receive FDA 510(k) Clearances in February Nov 4, 2020 OraSure Q3 Revenues Jump 33 Percent Oct 2, 2020 Qiagen Moves Ahead After Thwarted Thermo Fisher Buyout With NeuMoDx as Key Growth Driver Oct 1, 2020 DiaSorin Gets FDA Approval for Six Hepatitis B Serology Tests Jun 15, 2020 NeuMoDx Molecular Nabs CE Mark for HIV Viral Load Assay May 5, 2020 Genedrive Hepatitis C Test Garners WHO Prequalification, Firm Plans £8M Raise Dec 6, 2019 Laboratory-Based Patient Care Project Moving From Theory to Practice Nov 8, 2019 Bioneer Gets CE Mark for HCV Assay Oct 11, 2019 Dialysis Firm Fresenius to Pay $5.2M to Settle Improper Medicare Billing Allegations Sep 24, 2019 Enzo Clinical Labs Gets NY State Approval for HBV Assay Sep 13, 2019 'Substantial Growth' Led This Lab to Replace its Testing Systems With Next-Generation Platforms Premium Jul 22, 2019 Roche Expands Global Access Program to Include Tuberculosis, Hepatitis, HPV Tests Apr 16, 2019 FIND, World Hepatitis Alliance Collaborate on HCV Outreach Mar 19, 2019 Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays Feb 20, 2019 Abbott Receives CE Mark for Hepatitis B Point-of-Care Test Feb 14, 2019 Quest Q4 Revenues Dip 1 Percent Load More Breaking News European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal AnPac Bio to Raise $5M in Private Placement Top Five Articles on 360Dx Last Week: Sherlock Bio's $2M Award; Nostics' POC Testing Plans; and More KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure
